352 related articles for article (PubMed ID: 33323975)
21. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
22. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
23. Pleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.
Bai PS; Xia N; Sun H; Kong Y
J Cell Mol Med; 2017 Nov; 21(11):3023-3043. PubMed ID: 28557334
[TBL] [Abstract][Full Text] [Related]
24. COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis.
Ma NF; Lau SH; Hu L; Xie D; Wu J; Yang J; Wang Y; Wu MC; Fung J; Bai X; Tzang CH; Fu L; Yang M; Su YA; Guan XY
Clin Cancer Res; 2008 Aug; 14(16):5061-8. PubMed ID: 18698024
[TBL] [Abstract][Full Text] [Related]
25. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
Kew MC
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
[TBL] [Abstract][Full Text] [Related]
27. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
28. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z
Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595
[TBL] [Abstract][Full Text] [Related]
29. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
Kim DG
Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.
Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X
Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421
[TBL] [Abstract][Full Text] [Related]
31. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma.
Liu XH; Lin J; Zhang SH; Zhang SM; Feitelson MA; Gao HJ; Zhu MH
World J Gastroenterol; 2008 Mar; 14(9):1346-52. PubMed ID: 18322946
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
[TBL] [Abstract][Full Text] [Related]
33. Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver.
Sekiba K; Otsuka M; Koike K
Semin Liver Dis; 2021 May; 41(2):142-149. PubMed ID: 33984871
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
Huang FY; Wong DK; Mak LY; Cheung TT; Seto WK; Yuen MF
Carcinogenesis; 2022 Aug; 43(7):671-681. PubMed ID: 35353897
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus X protein overcomes all-trans retinoic acid-induced cellular senescence by downregulating levels of p16 and p21 via DNA methylation.
Park SH; Jung JK; Lim JS; Tiwari I; Jang KL
J Gen Virol; 2011 Jun; 92(Pt 6):1309-1317. PubMed ID: 21325480
[TBL] [Abstract][Full Text] [Related]
36. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China.
Zhu P; Tan D; Peng Z; Liu F; Song L
Acta Biochim Biophys Sin (Shanghai); 2007 Apr; 39(4):265-72. PubMed ID: 17417681
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic knockdown of Notch1 inhibits hepatitis B virus X protein‑induced hepatocarcinogenesis of L02/HBx cells.
Peng Y; Zhou D; Ye Y; Kai C; Jiang Z; Zhu Z; Wu X; Xiong J
Oncol Rep; 2019 Feb; 41(2):1151-1159. PubMed ID: 30431136
[TBL] [Abstract][Full Text] [Related]
39. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
40. C-terminal-truncated hepatitis B virus X protein enhances the development of diethylnitrosamine-induced hepatocellular carcinogenesis.
Quetier I; Brezillon N; Revaud J; Ahodantin J; DaSilva L; Soussan P; Kremsdorf D
J Gen Virol; 2015 Mar; 96(Pt 3):614-625. PubMed ID: 25519169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
